The JAK2/STAT3 inhibitor pacritinib effectively inhibits patient-derived GBM brain tumor initiating cells in vitro and when used in combination with temozolomide increases survival in an orthotopic xenograft modelKatharine V. Jensen, H. Artee Luchman|PLoS ONE|2017Cited by 68
Prostate Epithelium-Specific Deletion of the Selenocysteine tRNA Gene Trsp Leads to Early Onset Intraepithelial NeoplasiaH. Artee Luchman, Frank R. Jirik|American Journal Of Pathology|2014Cited by 18